JNJ vs INCY
By Alex · Tickerpine
Johnson & Johnson vs Incyte Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | INCY |
|---|---|---|
| Price | $254.66 | $113.75 |
| Market cap | $613.02B | $22.73B |
| P/E ratio | 29.5 | 16.1 |
| ROE | 26.42% | 30.82% |
| Profit margin | 21.83% | 26.71% |
| Revenue growth | 9.90% | 20.90% |
| Dividend yield | 2.10% | — |
| Beta | 0.26 | 0.79 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs INCY in plain English
- JNJ is the bigger company — about 27.0× the market cap of INCY.
- INCY is cheaper on earnings (P/E 16.1 vs 29.5).
- INCY earns a higher return on equity (31% vs 26%).
- INCY is growing revenue faster (21% vs 10%).
- JNJ pays a dividend (2.10%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
INCY return calculator
See what $1,000 in Incyte Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.